Lasa Supergenerics Limited - Asset Resilience Ratio

Latest as of September 2025: 1.14%

Lasa Supergenerics Limited (LASA) has an Asset Resilience Ratio of 1.14% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Rs8.16 Million

≈ $88.20K USD Cash + Short-term Investments

Total Assets

Rs716.03 Million

≈ $7.74 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2025)

This chart shows how Lasa Supergenerics Limited's Asset Resilience Ratio has changed over time. Check Lasa Supergenerics Limited (LASA) strategic investment index to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Lasa Supergenerics Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Lasa Supergenerics Limited.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs4.08 Million	0.57%
Short-term Investments	Rs4.08 Million	0.57%
Total Liquid Assets	Rs8.16 Million	1.14%

Asset Resilience Insights

Limited Liquidity: Lasa Supergenerics Limited maintains only 1.14% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company maintains a balanced mix of cash and short-term investments.

Lasa Supergenerics Limited Industry Peers by Asset Resilience Ratio

Compare Lasa Supergenerics Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Beijing Sun Novo Pharmaceutical Research Co Ltd SHG:688621	Drug Manufacturers - Specialty & Generic	2.04%
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	Drug Manufacturers - Specialty & Generic	0.01%
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	Drug Manufacturers - Specialty & Generic	7.85%
Jw Pharmac KO:001060	Drug Manufacturers - Specialty & Generic	3.65%
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Samjin Pharm KO:005500	Drug Manufacturers - Specialty & Generic	0.25%

Annual Asset Resilience Ratio for Lasa Supergenerics Limited (2017–2025)

The table below shows the annual Asset Resilience Ratio data for Lasa Supergenerics Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	1.01%	Rs10.30 Million ≈ $111.39K	Rs1.02 Billion ≈ $10.98 Million	-0.16pp
2024-03-31	1.18%	Rs17.75 Million ≈ $192.00K	Rs1.51 Billion ≈ $16.32 Million	-0.64pp
2023-03-31	1.81%	Rs29.69 Million ≈ $321.10K	Rs1.64 Billion ≈ $17.72 Million	-4.07pp
2022-03-31	5.88%	Rs123.02 Million ≈ $1.33 Million	Rs2.09 Billion ≈ $22.62 Million	+5.34pp
2021-03-31	0.54%	Rs11.23 Million ≈ $121.40K	Rs2.08 Billion ≈ $22.48 Million	-66.57pp
2020-03-31	67.11%	Rs1.56 Billion ≈ $16.84 Million	Rs2.32 Billion ≈ $25.09 Million	+66.95pp
2019-03-31	0.16%	Rs4.21 Million ≈ $45.51K	Rs2.58 Billion ≈ $27.96 Million	-0.76pp
2018-03-31	0.92%	Rs26.35 Million ≈ $284.94K	Rs2.87 Billion ≈ $31.01 Million	-0.04pp
2017-03-31	0.96%	Rs21.82 Million ≈ $236.03K	Rs2.28 Billion ≈ $24.68 Million	--

pp = percentage points

About Lasa Supergenerics Limited

NSE:LASA India Drug Manufacturers - Specialty & Generic

Market Cap

$3.75 Million

Rs347.20 Million INR

Market Cap Rank

#29055 Global

#1619 in India

Share Price

Rs6.93

Change (1 day)

+0.87%

52-Week Range

Rs5.67 - Rs13.92

All Time High

Rs206.80